Sanofi Elitek For Uric Acid Management Will Launch By Mid-August
Sanofi-Synthelabo plans to launch Elitek for the management of uric acid in pediatric oncology patients by mid-August
You may also be interested in...
Ilex Oncology appears to fit the profile of recently acquired companies within the biotechnology industry.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials